Who owns UNITED THERAPEUTICS Corp (UTHR)? Elite investor 13F holders
5 tracked elite investors reported holding UNITED THERAPEUTICS Corp as of 2026-06-30, including Renaissance Technologies LLC, Bridgewater Associates, Gotham Asset Management, GMO, Ancora Advisors / Ancora Holdings. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil)…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 925846052.00 USD | 1708739.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 60319767.00 USD | 111326.000000 | Shares | add | Original filing |
| D.E. Shaw | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Gotham Asset Management | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 42871215.00 USD | 79123.000000 | Shares | reduce | Original filing |
| GMO | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 1775577.00 USD | 3277.000000 | Shares | reduce | Original filing |
| Mairs & Power Funds | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Ancora Advisors / Ancora Holdings | UNITED THERAPEUTICS CORP DEL | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 5418.00 USD | 10.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.